newsfilter
← Latest News
GlobeNewswire·

Profound Medical to Participate in the Stifel 2026 Healthcare Conference

  • Profound Medical Corp. President Richard Fabian will present at the Stifel 2026 Healthcare Conference on November 12, 2026, at 8:40 a.m. Eastern Time in NYC.
  • The presentation will be broadcast live & archived on the company website.
  • Fabian, CEO Arun Menawat, & CFO Matthew Sobczyk will hold one-on-one meetings with investors during the conference.
  • Profound's flagship platform TULSA-PRO enables MRI-guided, incision-free prostate ablation for personalized treatment strategies.
  • The company commercializes Sonalleve, an MRI-guided therapy for bone metastases, tumors, gynecologic conditions, & other applications.
  • TULSA-PRO is FDA-cleared in the US & approved in Europe, Canada, Saudi Arabia, India, Australia/New Zealand, & the UAE.
  • Sonalleve is an FDA HDE-approved treatment in the US for osteoid osteomas & is cleared in Europe, Canada, China, & Saudi Arabia.
  • Profound's technologies utilize real-time MRI guidance to provide incision-free treatment options with minimal side effects.
Company
Profound Medical Inc.
Keywords
Toronto Stock Exchange:PRN, Profound Medical Inc., NASDAQ:PROF, PROF, PRN, Profound, Profound Medical, prostate, TULSA, Sonalleve, Menawat, Richard Fabian, Stifel